1. US Food and Drug Administration MedWatch http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm174474.htm
2. US Food and Drug Administration MedWatch http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm180694.htm
3. Malignancy and rheumatoid arthritis;Askling;Curr Rheumatol Rep,2007
4. Malignancy and biologic therapy in rheumatoid arthritis;Askling;Curr Opin Rheumatol,2008